Healthcare Asia Pharma Awards 2024: Bushu Pharmaceuticals
Bushu Pharmaceuticals' ESG Promotion Manager, Yasuko Watanabe, discusses the company's commitment to sustainability in healthcare, including CO2 reduction initiatives and wastewater treatment upgrades.
Learn how they clinched the ESG Program of the Year - Japan and Sustainability Initiative of the Year - Japan accolades at the Healthcare Asia Pharma Awards 2024 by clicking here.
Commentary
Biomedical textiles: Novel fabrics supporting enhanced patient care in Asia-Pacific